Conhecimento de parecer técnico
#7.1
06/30/2026
RPI 2895
Application data
Number
112020005120Type
Filing
Publication
PCT
EP2018074449 The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.
Latest action published by the INPI: 06/30/2026. We update with every new RPI gazette, published weekly.
Applicants
BIONTECH RNA PHARMACEUTICALS GMBH
DE
B. S. (pessoa física)
DE
TRON - TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSIÄT MAINZ GEMEINNÜTZIGE GMBH
DE
Inventors
A. K. (pessoa física)
DE
M. P. (pessoa física)
DE
M. P. (pessoa física)
DE
T. B. (pessoa física)
DE
U. S. (pessoa física)
DE
IPC Classification
Priority claims
EP
PCT/EP2017/073065 · 09/13/2017
Abstract
The present invention describes a virus-derived factor which when provided to cells, e.g., by transfecting the cells with RNA encoding the virus-derived factor, enhances expression of RNA encoding a peptide or protein in the cells. In particular, the virus-derived factor enhances survival of cells, in particular when transfected repetitively with RNA, and reduces an IFN response of cells to transfected RNA. Accordingly, the present invention provides methods and means for enhancing expression of RNA in cells. The cells are preferably transfected with the RNA.
Publications in the Brazilian Industrial Property Gazette (RPI).
#7.1
06/30/2026
RPI 2895
#6.23
09/17/2024
RPI 2802
#25.1
05/17/2022
RPI 2680
#15.35
11/23/2021
RPI 2655
#1.3
09/24/2020
RPI 2594
#1.1
03/24/2020
RPI 2568
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.